ACS Chemical Neuroscience · 2023 · 27 citations · 49 references
PharmacyMedicinal ChemistryNeuroscienceBiomedical ImagingMolecular ImagingMolecular RecognitionChemical Probe DiscoveryFluorescence ImagingMolecular Probe DevelopmentTargeted Imaging AgentsBlood-brain Barrier PermeabilityFluorescence Imaging ProbesFluorescence ProbesFluorescent Probe DesignFluorescent ProbesFluorophore DesignIn Vivo Fluorescence ImagingTransgenic Mice
Amyloid-β (Aβ) is the core constituent protein of senile plaques, which is one of the key pathological hallmarks of Alzheimer’s disease (AD). Here we describe the design, synthesis, and evaluation of coumarin-derived small molecule fluorophores for Aβ imaging. By embedding the aromatic coumarin framework into π bridge of a push–pull chromophore, a novel fluorescence probe XCYC-3 applicable to efficient Aβ recognition was discovered. XCYC-3 displays higher fluorescent enhancement for aggregated Aβ than monomeric Aβ, and possesses good blood-brain barrier permeability. In vitro staining and in vivo imaging studies demonstrated that XCYC-3 could efficiently recognize Aβ plaques in the brain of AD transgenic mice. These results suggest that XCYC-3 is a promising fluorescence imaging agent for Aβ, which might provide important clues for the future development of potent NIR fluorescent probes for Aβ diagnosis.
49
Holly D. Oakley, Sarah L. Cole, Sreemathi Logan et al. · Journal of Neuroscience · 2006 · 3.6K citations · Full text
Chongzhao Ran, Xiaoyin Xu, Scott B. Raymond et al. · Journal of the American Chemical Society · 2009 · 484 citations · Full text
Medicine, Neurology, Neuroscience +17